Axilyta 5 : Axitinib 5mg Tablets
Axilyta 5 – Axitinib 5mg Tablet is a targeted therapy used primarily in the treatment of advanced renal cell carcinoma (RCC) (kidney cancer). It is a potent, selective inhibitor of vascular endothelial growth factor (VEGF) receptors 1, 2, and 3, which play a critical role in tumor angiogenesis. By blocking these receptors, Axilyta 5 – Axitinib 5mg helps to reduce the blood supply to tumors, potentially slowing their growth and spread.